Alex Abramson, PhD is an Assistant Professor in the School of Chemical and Biomolecular Engineering at Georgia Tech and is a faculty member of the Bioengineering PhD Program. He also holds a courtesy appointment in Biomedical Engineering Department. His research, which focuses on drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Dr. Abramson has received several recognitions for scientific innovation, including being named a member of the Forbes 30 Under 30 Science List and the MIT Technology Review Innovators Under 35 List. Dr. Abramson is passionate about translating scientific endeavors from bench to bedside. Large pharmaceutical companies have exclusively licensed a portfolio of his patents to bring into clinical trials, and Dr. Abramson serves as a scientific advisor overseeing their commercialization. In addition to his scientific endeavors, Dr. Abramson plays an active role in his community by leading Diversity, Equity, and Inclusion efforts on campus and volunteering as a STEM tutor to local students.
Prof. Abramson received his B.S. in Chemical and Biomolecular Engineering from Johns Hopkins University and his Ph.D. in Chemical Engineering from MIT as an NSF Graduate Research Fellow under the direction of Profs. Robert Langer and Giovanni Traverso. He conducted postdoctoral work at Stanford University as an NIH fellow with Profs. Zhenan Bao and the late Sanjiv S. Gambhir. CV. Scholar.
Faculty Support Coordinator: Maise Parham (email@example.com)